73 related articles for article (PubMed ID: 26323927)
1. A comparison of consistency of detecting c-MET gene amplification in peripheral blood and tumor tissue of nonsmall cell lung cancer patients.
Chen D; Xu C; Wu J; Zhang Y; Fang M
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C63-7. PubMed ID: 26323927
[TBL] [Abstract][Full Text] [Related]
2. A comparison of consistency of detecting BRAF gene mutations in peripheral blood and tumor tissue of nonsmall-cell lung cancer patients.
Fang M; Xu C; Wu J; Zhang Y; He C
J Cancer Res Ther; 2014 Nov; 10 Suppl():C150-4. PubMed ID: 25450274
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the c-MET gene amplification between primary tumor and metastatic lymph nodes in non-small cell lung cancer.
Xu CW; Wang WX; Wu MJ; Zhu YC; Zhuang W; Lin G; Du KQ; Huang YJ; Chen YP; Chen G; Fang MY
Thorac Cancer; 2017 Sep; 8(5):417-422. PubMed ID: 28590585
[TBL] [Abstract][Full Text] [Related]
4. Combined detection of CEA, CK-19 and c-met mRNAs in peripheral blood: a highly sensitive panel for potential molecular diagnosis of non-small cell lung cancer.
Sheu CC; Chang MY; Chang HC; Tsai JR; Lin SR; Chang SJ; Hwang JJ; Huang MS; Chong IW
Oncology; 2006; 70(3):203-11. PubMed ID: 16809939
[TBL] [Abstract][Full Text] [Related]
5. High MET receptor expression but not gene amplification in ALK 2p23 rearrangement positive non-small-cell lung cancer.
Feng Y; Minca EC; Lanigan C; Liu A; Zhang W; Yin L; Pennell NA; Farver C; Tubbs R; Ma PC
J Thorac Oncol; 2014 May; 9(5):646-53. PubMed ID: 24722154
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of acquired resistance-related molecules in Japanese patients with NSCLC treated with an EGFR-TKI.
Uramoto H; Yamada T; Yano S; Kondo N; Hasegawa S; Tanaka F
Anticancer Res; 2012 Sep; 32(9):3785-90. PubMed ID: 22993320
[TBL] [Abstract][Full Text] [Related]
7. High MET gene copy number leads to shorter survival in patients with non-small cell lung cancer.
Go H; Jeon YK; Park HJ; Sung SW; Seo JW; Chung DH
J Thorac Oncol; 2010 Mar; 5(3):305-13. PubMed ID: 20107422
[TBL] [Abstract][Full Text] [Related]
8. Impact of bevacizumab in combination with erlotinib on EGFR-mutated non-small cell lung cancer xenograft models with T790M mutation or MET amplification.
Furugaki K; Fukumura J; Iwai T; Yorozu K; Kurasawa M; Yanagisawa M; Moriya Y; Yamamoto K; Suda K; Mizuuchi H; Mitsudomi T; Harada N
Int J Cancer; 2016 Feb; 138(4):1024-32. PubMed ID: 26370161
[TBL] [Abstract][Full Text] [Related]
9. High-MET status in non-small cell lung tumors correlates with receptor phosphorylation but not with the serum level of soluble form.
Copin MC; Lesaffre M; Berbon M; Doublet L; Leroy C; Tresch E; Porte H; Vicogne J; B Cortot A; Dansin E; Tulasne D
Lung Cancer; 2016 Nov; 101():59-67. PubMed ID: 27794409
[TBL] [Abstract][Full Text] [Related]
10. Shedding of c-Met ectodomain correlates with c-Met expression in non-small cell lung cancer.
Fu L; Guo W; Liu B; Sun L; Bi Z; Zhu L; Wang X; Liu B; Xie Q; Li K
Biomarkers; 2013 Mar; 18(2):126-35. PubMed ID: 23410046
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.
Cheng TL; Chang MY; Huang SY; Sheu CC; Kao EL; Cheng YJ; Chong IW
Chest; 2005 Sep; 128(3):1453-60. PubMed ID: 16162743
[TBL] [Abstract][Full Text] [Related]
12. c-MET/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas.
Tsuta K; Kozu Y; Mimae T; Yoshida A; Kohno T; Sekine I; Tamura T; Asamura H; Furuta K; Tsuda H
J Thorac Oncol; 2012 Feb; 7(2):331-9. PubMed ID: 22198430
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival.
Lutterbach B; Zeng Q; Davis LJ; Hatch H; Hang G; Kohl NE; Gibbs JB; Pan BS
Cancer Res; 2007 Mar; 67(5):2081-8. PubMed ID: 17332337
[TBL] [Abstract][Full Text] [Related]
14. DNA repair gene expression level in peripheral blood and tumour tissue from non-small cell lung cancer and head and neck squamous cell cancer patients.
Schena M; Guarrera S; Buffoni L; Salvadori A; Voglino F; Allione A; Pecorari G; Ruffini E; Garzino-Demo P; Bustreo S; Consito L; Bironzo P; Matullo G
DNA Repair (Amst); 2012 Apr; 11(4):374-80. PubMed ID: 22284908
[TBL] [Abstract][Full Text] [Related]
15. Parallel screening for ALK, MET and ROS1 alterations in non-small cell lung cancer with implications for daily routine testing.
Jurmeister P; Lenze D; Berg E; Mende S; Schäper F; Kellner U; Herbst H; Sers C; Budczies J; Dietel M; Hummel M; von Laffert M
Lung Cancer; 2015 Feb; 87(2):122-9. PubMed ID: 25534130
[TBL] [Abstract][Full Text] [Related]
16. MET tyrosine kinase inhibitor crizotinib (PF-02341066) shows differential antitumor effects in non-small cell lung cancer according to MET alterations.
Tanizaki J; Okamoto I; Okamoto K; Takezawa K; Kuwata K; Yamaguchi H; Nakagawa K
J Thorac Oncol; 2011 Oct; 6(10):1624-31. PubMed ID: 21716144
[TBL] [Abstract][Full Text] [Related]
17. MET amplification status in therapy-naïve adeno- and squamous cell carcinomas of the lung.
Schildhaus HU; Schultheis AM; Rüschoff J; Binot E; Merkelbach-Bruse S; Fassunke J; Schulte W; Ko YD; Schlesinger A; Bos M; Gardizi M; Engel-Riedel W; Brockmann M; Serke M; Gerigk U; Hekmat K; Frank KF; Reiser M; Schulz H; Krüger S; Stoelben E; Zander T; Wolf J; Buettner R
Clin Cancer Res; 2015 Feb; 21(4):907-15. PubMed ID: 25492085
[TBL] [Abstract][Full Text] [Related]
18. Impaired c-Met Receptor Degradation Mediated by MET Exon 14 Mutations in Non-Small-Cell Lung Cancer.
Awad MM
J Clin Oncol; 2016 Mar; 34(8):879-81. PubMed ID: 26786927
[No Abstract] [Full Text] [Related]
19. Expression of MET and SOX2 genes in non-small cell lung carcinoma with EGFR mutation.
Cai YR; Zhang HQ; Qu Y; Mu J; Zhao D; Zhou LJ; Yan H; Ye JW; Liu Y
Oncol Rep; 2011 Oct; 26(4):877-85. PubMed ID: 21687954
[TBL] [Abstract][Full Text] [Related]
20. Quantification of serum MET in non-small-cell lung cancer and its clinical significance.
Li D; Li F; Wu Y; Zhou D; Chen H
Clin Biochem; 2015 Feb; 48(3):110-4. PubMed ID: 25489726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
